Chih-Ho Lai Selected Research

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)

11/2014	Association of promoter genetic variants in interleukin-10 and Kawasaki disease with coronary artery aneurysms.
1/2009	Interleukin-18 gene 105A/C genetic polymorphism is associated with the susceptibility of Kawasaki disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chih-Ho Lai Research Topics

Disease

32	Neoplasms (Cancer) 08/2021 - 05/2009
18	Infections 01/2022 - 10/2008
16	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2014
16	Inflammation (Inflammations) 01/2022 - 10/2008
8	Stomach Neoplasms (Stomach Cancer) 08/2021 - 08/2008
4	Mouth Neoplasms (Oral Cancer) 01/2019 - 07/2010
4	Cardiovascular Diseases (Cardiovascular Disease) 06/2018 - 12/2017
4	Hyperlipidemias (Hyperlipidemia) 06/2018 - 12/2017
4	Squamous Cell Carcinoma of Head and Neck 09/2014 - 07/2010
3	Type 2 Diabetes Mellitus (MODY) 02/2021 - 02/2017
3	Disease Progression 01/2016 - 07/2010
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2011 - 10/2008
3	Hypoxia (Hypoxemia) 07/2011 - 07/2009
2	Hypercholesterolemia 08/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 11/2019 - 08/2011
2	Carcinogenesis 08/2019 - 09/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2019 - 08/2009
2	Fibrosis (Cirrhosis) 01/2019 - 11/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2018 - 01/2017
2	Peptic Ulcer (Peptic Ulcers) 01/2017 - 08/2008
2	Communicable Diseases (Infectious Diseases) 01/2016 - 06/2015
2	Fever (Fevers) 10/2015 - 01/2013
2	Bacterial Infections (Bacterial Infection) 01/2015 - 02/2014
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 11/2014 - 01/2009
2	Ischemia 07/2011 - 02/2011
2	Medulloblastoma 03/2010 - 10/2008
1	Gastroenteritis 01/2022
1	Leptospirosis 01/2022
1	Diabetes Mellitus 02/2021
1	Hypopharyngeal Neoplasms 02/2021
1	medullary Thyroid cancer 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Scarlet Fever 01/2021
1	Cross Infection (Nosocomial Infection) 03/2020

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2008
10	Pharmaceutical PreparationsIBA 08/2021 - 07/2011
6	CholesterolIBA 12/2021 - 10/2011
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2021 - 01/2016
6	cytolethal distending toxinIBA 01/2021 - 05/2014
6	CytokinesIBA 01/2020 - 10/2008
5	Anti-Bacterial Agents (Antibiotics)IBA 03/2020 - 08/2008
5	LipidsIBA 10/2019 - 06/2015
5	Biomarkers (Surrogate Marker)IBA 09/2014 - 07/2010
4	Biological ProductsIBA 01/2022 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2010
4	Interleukin-8 (Interleukin 8)IBA 01/2020 - 03/2010
4	Cytotoxins (Cytolysins)IBA 01/2016 - 10/2011
3	Messenger RNA (mRNA)IBA 01/2022 - 07/2009
3	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2008
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 08/2021 - 09/2015
3	Therapeutic UsesIBA 08/2021 - 10/2013
3	NF-kappa B (NF-kB)IBA 01/2020 - 05/2009
3	Antineoplastic Agents (Antineoplastics)IBA 11/2018 - 01/2015
3	Simvastatin (Zocor)FDA LinkGeneric 01/2018 - 01/2016
3	glutaryl-coenzyme A (glutaryl-CoA)IBA 01/2018 - 01/2016
3	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2018 - 01/2016
3	ChitosanIBA 09/2015 - 05/2014
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 11/2014
2	SolutionsIBA 08/2021 - 08/2014
2	Hyaluronic Acid (Hyaluronan)IBA 08/2021 - 11/2016
2	Virulence Factors (Pathogenicity Factors)IBA 08/2021 - 01/2013
2	MutagensIBA 02/2021 - 01/2021
2	LigandsIBA 01/2020 - 11/2016
2	Small Interfering RNA (siRNA)IBA 08/2019 - 09/2011
2	Arecoline (Arecolin)IBA 01/2019 - 07/2010
2	LipopolysaccharidesIBA 01/2017 - 10/2015
2	Intravenous Immunoglobulins (IVIG)FDA Link 10/2015 - 01/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2015 - 05/2009
2	GelatinIBA 09/2015 - 08/2014
2	FucoseIBA 09/2015 - 08/2014
2	CalciumIBA 01/2015 - 07/2011
2	Heparin (Liquaemin)FDA LinkGeneric 05/2014 - 02/2011
2	AntioxidantsIBA 01/2014 - 04/2013
2	Type IV Secretion SystemsIBA 01/2012 - 10/2011
2	LumicanIBA 11/2011 - 01/2010
2	InterferonsIBA 09/2011 - 03/2010
2	Monoclonal AntibodiesIBA 08/2011 - 05/2009
2	Connective Tissue Growth FactorIBA 08/2011 - 05/2009
2	IntegrinsIBA 08/2011 - 05/2009
2	Peptides (Polypeptides)IBA 07/2011 - 05/2009
1	AndrogensIBA 01/2022
1	sphingosine kinaseIBA 01/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 08/2021
1	P-SelectinIBA 08/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2021
1	Succinic Acid (Succinate)IBA 08/2021
1	fucoidanIBA 08/2021
1	Metformin (Glucophage)FDA LinkGeneric 02/2021
1	SuperantigensIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	Cyclin-Dependent Kinase 5IBA 01/2021
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2021
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021
1	Rifabutin (Ansamycin)FDA Link 07/2020
1	Anti-Infective Agents (Microbicides)IBA 03/2020

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2014
4	Castration 01/2022 - 01/2014
4	Radiotherapy 02/2021 - 07/2014
2	Art Therapy 06/2018 - 12/2017
2	Oral Administration 01/2018 - 09/2015